Noda, Japan

Haruki Sayama

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kikkoman Corporation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruki Sayama. Retrieved from https://idiyas.com/inventor/haruki-sayama-esd719ld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haruki Sayama and a Novel Approach to Tomato Yellow Leaf Curl Virus

Introduction

Haruki Sayama is an inventor associated with Kikkoman Corporation in Noda, Japan. His patent work addresses tomato yellow leaf curl virus (TYLCV) and approaches to interrupting its transmission cycle.

Latest Patents

Sayama is associated with 1 patent, titled “Non-entomophilous tomato yellow leaf curl virus.” The invention describes a novel TYLCV that is not transmitted by an insect vector. Its stated aim is to help break the virus’s infection cycle and support methods for controlling tomato yellow leaf curl disease and preventing virus transmission.

Career Highlights

The available information identifies Sayama’s work with Kikkoman Corporation and highlights his contribution to research on virus control in tomatoes. The patent focuses on a non-insect-transmitted virus as a potential tool for managing TYLCV.

Collaborations

Sayama’s listed coworkers include Toshiro Inoue and Hisashi Nishigawa.

Conclusion

Haruki Sayama’s patent presents a distinctive approach to TYLCV management by focusing on a virus that is not transmitted by insect vectors, with the goal of disrupting transmission and helping control tomato disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…